Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 484161, 8 pages
http://dx.doi.org/10.1155/2014/484161
Research Article

Merit of Ginseng in the Treatment of Heart Failure in Type 1-Like Diabetic Rats

1Department of Neurosurgery, Mackay Memorial Hospital, Taipei 104, Taiwan
2Graduate Institute of Injury Prevention and Control, Taipei Medical University, Taipei 110, Taiwan
3Department of Cardiology, College of Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
4Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
5Department of Neurosurgery, College of Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei 110, Taiwan
6Department of Cardiothoracic Surgery, Shanghai East Hospital, Tongji University, Shanghai, China

Received 16 January 2014; Accepted 6 February 2014; Published 17 March 2014

Academic Editor: Juei-Tang Cheng

Copyright © 2014 Cheng-Chia Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. B. Kannel, M. Hjortland, and W. P. Castelli, “Role of diabetes in congestive heart failure: the Framingham study,” American Journal of Cardiology, vol. 34, no. 1, pp. 29–34, 1974. View at Google Scholar · View at Scopus
  2. W. B. Kannel and D. L. McGee, “Diabetes and cardiovascular disease. The Framingham study,” Journal of the American Medical Association, vol. 241, no. 19, pp. 2035–2038, 1979. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Malmberg and L. Ryden, “Myocardial infarction in patients with diabetes mellitus,” European Heart Journal, vol. 9, no. 3, pp. 259–264, 1988. View at Google Scholar · View at Scopus
  4. J. Herlitz, K. Malmberg, B. W. Karlson, L. Ryden, and A. Hjalmarson, “Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction,” Acta Medica Scandinavica, vol. 224, no. 1, pp. 31–38, 1988. View at Google Scholar · View at Scopus
  5. I. G. Poornima, P. Parikh, and R. P. Shannon, “Diabetic cardiomyopathy: the search for a unifying hypothesis,” Circulation Research, vol. 98, no. 5, pp. 596–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. An and B. Rodrigues, “Role of changes in cardiac metabolism in development of diabetic cardiomyopathy,” American Journal of Physiology, vol. 291, no. 4, pp. H1489–H1506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Karmazyn, M. Moey, and X. T. Gan, “Therapeutic potential of ginseng in the management of cardiovascular disorders,” Drugs, vol. 71, no. 15, pp. 1989–2008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Guo, X. T. Gan, J. V. Haist et al., “Ginseng inhibits cardiomyocyte hypertrophy and heart failure via nhe-1 inhibition and attenuation of calcineurin activation,” Circulation, vol. 4, no. 1, pp. 79–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Frey and E. N. Olson, “Cardiac hypertrophy: the good, the bad, and the ugly,” Annual Review of Physiology, vol. 65, pp. 45–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Berry, V. Le, D. Rotter et al., “Reversibility of adverse, calcineurin-dependent cardiac remodeling,” Circulation Research, vol. 109, no. 4, pp. 407–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Yang and Y. Li, “Roles of PPARs on regulating myocardial energy and lipid homeostasis,” Journal of Molecular Medicine, vol. 85, no. 7, pp. 697–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Issemann and S. Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Cheng, G. Ding, Q. Qin et al., “Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy,” Nature Medicine, vol. 10, no. 11, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Cheng, G. Ding, Q. Qin et al., “Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 313, no. 2, pp. 277–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D. Barish, V. A. Narkar, and R. M. Evans, “PPARδ: a dagger in the heart of the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 590–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B.-C. Yu, C.-K. Chang, H.-Y. Ou, K.-C. Cheng, and J.-T. Cheng, “Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats,” Cardiovascular Research, vol. 80, no. 1, pp. 78–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. S. Fein, L. B. Kornstein, and J. E. Strobeck, “Altered myocardial mechanics in diabetic rats,” Circulation Research, vol. 47, no. 6, pp. 922–933, 1980. View at Google Scholar · View at Scopus
  18. F. S. Fein, J. E. Strobeck, and A. Malhotra, “Reversibility of diabetic cardiomyopathy with insulin in rats,” Circulation Research, vol. 49, no. 6, pp. 1251–1261, 1981. View at Google Scholar · View at Scopus
  19. M. T. Chou, S. H. Lo, K. C. Cheng, Y. X. Li, L. J. Chen, and J. T. Cheng, “Activation of β-adrenoceptors by dobutamine may induce a higher expression of peroxisome proliferator-activated receptors δ (PPARδ) in neonatal rat cardiomyocytes,” The Scientific World Journal, vol. 2012, Article ID 248320, 8 pages, 2012. View at Publisher · View at Google Scholar
  20. Z.-C. Chen, B.-C. Yu, L.-J. Chen, K.-C. Cheng, H. J. Lin, and J.-T. Cheng, “Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line,” British Journal of Pharmacology, vol. 163, no. 2, pp. 390–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zhao, W. D. Cai, Y. X. Gan et al., “A comparison of HIV infection and related risk factors between money boys and noncommercial men who have sex with men in Shenzhen, China,” Sexually Transmitted Diseases, vol. 39, no. 12, pp. 942–948, 2012. View at Publisher · View at Google Scholar
  22. S. C. Fan, B. C. Yu, Z. C. Chen, L. J. Chen, H. H. Chung, and J. T. Cheng, “The decreased expression of Peroxisome Proliferator-Activated Receptors (PPAR) is reversed by digoxin in the heart of diabetic rats,” Hormone and Metabolic Research, vol. 42, no. 9, pp. 637–642, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. G. Shearer, D. J. Steger, J. M. Way et al., “Identification and characterization of a selective peroxisome proliferator-activated receptor β/δ (NR1C2) antagonist,” Molecular Endocrinology, vol. 22, no. 2, pp. 523–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. C. Chen, K. S. Lee, L. J. Chen, L. Y. Wang, H. S. Niu, and J. T. Cheng, “Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate,” PLoS ONE, vol. 8, no. 5, Article ID e64229, 2013. View at Publisher · View at Google Scholar
  25. S. I. Seldinger, “Catheter replacement of the needle in percutaneous arteriography: a new technique,” Acta Radiologica, vol. 49, no. 434, pp. 47–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Layland, R. J. Solaro, and A. M. Shah, “Regulation of cardiac contractile function by troponin I phosphorylation,” Cardiovascular Research, vol. 66, no. 1, pp. 12–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Metzger and M. V. Westfall, “Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation,” Circulation Research, vol. 94, no. 2, pp. 146–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Kobayashi, L. Jin, and P. P. de Tombe, “Cardiac thin filament regulation,” Pflugers Archiv, vol. 457, no. 1, pp. 37–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Paterniti, E. Esposito, E. Mazzon et al., “Evidence for the role of peroxisome proliferator-activated receptor-β/δ in the development of spinal cord injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 2, pp. 465–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Y. Wang, J. Y. Yang, F. Wang et al., “Neuroprotective effect of pseudoginsenoside-F11 on a rat model of Parkinson's disease induced by 6-hydroxydopamine,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 152798, 9 pages, 2013. View at Publisher · View at Google Scholar
  31. L. Pei, H. Shaozhen, D. Gengting, C. Tingbo, L. Liang, and Z. Hua, “Effectiveness of Panax ginseng on acute myocardial ischemia reperfusion injury was abolished by flutamide via endogenous testosterone-mediated akt pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 817826, 9 pages, 2013. View at Publisher · View at Google Scholar
  32. K. H. Lim, D. Ko, and J. H. Kim, “Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats,” Journal of Ginseng Research, vol. 37, no. 3, pp. 273–282, 2013. View at Publisher · View at Google Scholar
  33. J. W. Lin, Y. G. Cherng, L. J. Chen, H. S. Niu, C. K. Chang, and C. S. Niu, “Ginseng is useful to enhance cardiac contractility in animals,” BioMed Research International, vol. 2014, Article ID 723084, 9 pages, 2014. View at Publisher · View at Google Scholar
  34. H.-X. Li, S.-Y. Han, X. Ma et al., “The saponin of red ginseng protects the cardiac myocytes against ischemic injury in vitro and in vivo,” Phytomedicine, vol. 19, no. 6, pp. 477–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Cavero, “10th annual meeting of the Safety Pharmacology Society: an overview,” Expert Opinion on Drug Safety, vol. 10, no. 2, pp. 319–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. W. C. Buhles, “Compassionate use: a story of ethics and science in the development of a new drug,” Perspectives in Biology and Medicine, vol. 54, no. 3, pp. 304–315, 2011. View at Google Scholar · View at Scopus
  37. T. Keida, N. Hayashi, and M. Kawashima, “Application of the Food and Drug Administration (FDA) bioequivalent guidance of topical dermatological corticosteroid in yellow-skinned Japanese population: validation study using a chromameter,” Journal of Dermatology, vol. 33, no. 10, pp. 684–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. B. D. Schaan, P. Dall'Ago, C. Y. Maeda et al., “Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats,” Brazilian Journal of Medical and Biological Research, vol. 37, no. 12, pp. 1895–1902, 2004. View at Google Scholar · View at Scopus
  39. G. R. Borges, M. de Oliveira, H. C. Salgado, and R. Fazan Jr., “Myocardial performance in conscious streptozotocin diabetic rats,” Cardiovascular Diabetology, vol. 5, article 26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Z. Cheng, L. J. Chen, W. J. Lee, M. F. Chen, H. J. Lin, and J. T. Cheng, “Increase of myocardial performance by Rhodiola-ethanol extract in diabetic rats,” Journal of Ethnopharmacology, vol. 144, no. 2, pp. 234–239, 2012. View at Publisher · View at Google Scholar
  41. H. Zhou, S. Z. Hou, P. Luo et al., “Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 287–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. G. I. Scott, P. B. Colligan, B. H. Ren, and J. Ren, “Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide,” British Journal of Pharmacology, vol. 134, no. 6, pp. 1159–1165, 2001. View at Google Scholar · View at Scopus
  43. S. Y. Kang, V. B. Schini-Kerth, and N. D. Kim, “Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta,” Life Sciences, vol. 56, no. 19, pp. 1577–1586, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. S. C. Kuo, P. M. Ku, L. J. Chen, H. S. Niu, and J. T. Cheng, “Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro,” Hormone and Metabolic Research, vol. 45, no. 12, pp. 880–886, 2013. View at Publisher · View at Google Scholar
  45. X. Liu, N. Takeda, and N. S. Dhalla, “Troponin I phosphorylation in heart homogenate from diabetic rat,” Biochimica et Biophysica Acta, vol. 1316, no. 2, pp. 78–84, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. A. E. Messer, A. M. Jacques, and S. B. Marston, “Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 1, pp. 247–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Ayaz-Guner, J. Zhang, L. Li, J. W. Walker, and Y. Ge, “In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated,” Biochemistry, vol. 48, no. 34, pp. 8161–8170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. G. A. MacGowan, C. Evans, T. C.-C. Hu et al., “Troponin I protein kinase C phosphorylation sites and ventricular function,” Cardiovascular Research, vol. 63, no. 2, pp. 245–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. C. A. Tate, M. F. Hyek, and G. E. Taffet, “The role of calcium in the energetics of contracting skeletal muscle,” Sports Medicine, vol. 12, no. 3, pp. 208–217, 1991. View at Google Scholar · View at Scopus
  50. L. Li, J. Desantiago, G. Chu, E. G. Kranias, and D. M. Bers, “Phosphorylation of phospholamban and troponin I in β-adrenergic-induced acceleration of cardiac relaxation,” American Journal of Physiology, vol. 278, no. 3, pp. H769–H779, 2000. View at Google Scholar · View at Scopus
  51. Y. Pi, K. R. Kemnitz, D. Zhang, E. G. Kranias, and J. W. Walker, “Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice,” Circulation Research, vol. 90, no. 6, pp. 649–656, 2002. View at Publisher · View at Google Scholar · View at Scopus